Asclepio-Revista de Historia de la Medicina y de la Ciencia, published by the Consejo Superior de Investigaciones Científicas (CSIC) in Spain, stands as a vital open-access journal dedicated to the interdisciplinary exploration of the history of medicine and science. Since its inception in 1969, the journal has evolved through various converged years, fostering critical discourse and dissemination of scholarly work till 2024. This journal holds a notable position in its field, classified within the Q3 category in History and Philosophy of Science, and ranks 141 out of 223 in Scopus, underscoring its relevance and contribution to academic research. With an unwavering commitment to open access since 1995, Asclepio provides facile access to its content, empowering researchers, professionals, and students alike to delve into the rich historical narratives that shape modern medical and scientific practices. The editorial office is located in Madrid at C/VITRUVIO 8, further enhancing its accessibility for local and international scholars.

JOURNAL OF PSYCHOACTIVE DRUGS, published by Routledge Journals, Taylor & Francis Ltd, stands as a leading resource in the fields of psychology and medicine, focusing on the intersection of psychoactive substances and their impact on human behavior. With an ISSN of 0279-1072 and E-ISSN 2159-9777, this esteemed journal has been a pivotal platform for rigorous research since its inception in 1967, contributing to the understanding of drug use, its societal implications, and therapeutic potentials. It currently holds a Q2 ranking in both the miscellaneous categories of Medicine and Psychology for 2023, reflecting its significant standing within academic circles. Moreover, its Scopus rankings place it at the 49th percentile in General Psychology and 101st in Medicine, underscoring its relevance in contemporary research. Although it is not available via Open Access, the journal maintains a commitment to advancing knowledge through its annual publications until 2024. JOURNAL OF PSYCHOACTIVE DRUGS is essential for researchers, professionals, and students seeking to explore the complexities of psychoactive substances and their effects in various contexts.

Sucht-Zeitschrift für Wissenschaft und Praxis, published by HOGREFE AG in Switzerland, is a pivotal journal addressing the interrelated fields of addiction science and mental health. With an ISSN of 0939-5911 and an E-ISSN of 1664-2856, this journal has been dedicated to fostering interdisciplinary research and practical applications since its inception in 1991, continuing through to 2024. As a respected source in the field, it holds a 2023 Q3 quartile ranking in Medicine (miscellaneous), a Q4 ranking in Psychiatry and Mental Health, and a Q3 ranking in Public Health, highlighting its broad relevance and growing impact on contemporary health discussions. While currently not offering open access options, the journal provides a rich platform for researchers, practitioners, and students to share and gain insights into innovative practices and scientific findings that advance the understanding of addiction and its societal implications. With its contributions indexed in Scopus and a variety of rankings reflective of its quality, Sucht-Zeitschrift für Wissenschaft und Praxis serves as an essential resource for those committed to advancing knowledge and practice in addiction-related fields.

The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.

Sociology of Health & Illness is a leading academic journal published by Wiley, dedicated to exploring the intricate relationships between health, illness, and society. With an ISSN of 0141-9889 and an e-ISSN of 1467-9566, this journal has established a significant presence since its inception in 1979, continuing to provide valuable insights through to 2024. Recognized in the Q1 quartile across multiple categories, including Health Policy, Health (Social Science), and Public Health, Environmental and Occupational Health, it ranks impressively at 52nd in Social Sciences and holds a robust reputation with a Scopus classification that places it within the top percentiles of its field. The journal’s objectives focus on publishing high-quality research that advances understanding of the social determinants of health and their implications, making it indispensable for scholars, professionals, and students committed to health-related research. Operating from its headquarters in the United Kingdom, **Sociology of Health & Illness** contributes significantly to the global discourse on health and social welfare, reinforcing its vital role in shaping knowledge and policy in health and social sciences.

International Journal of Drug Policy, published by Elsevier, stands as a crucial scholarly platform dedicated to advancing the field of drug policy research. With an impactful focus on health policy and medicine, this journal holds a prestigious Q1 ranking in both Health Policy and Medicine (miscellaneous) categories as of 2023, reflecting its high-quality contributions to the discourse surrounding drug use, regulation, and public health. Spanning publication from 1998 to 2024, the journal's rich archive of research serves as an essential resource for researchers, professionals, and students alike. While the journal is not open access, it provides invaluable insights and significant findings that drive policy-making decisions and foster evidence-based practices in drug management and health interventions. With a Scopus rank of #28 out of 310 in Health Policy and #55 out of 398 in Medicine (miscellaneous), the International Journal of Drug Policy is indispensable for those committed to exploring and understanding the complexities of drug-related issues on a global scale.

BioSocieties is a distinguished scholarly journal published by Palgrave Macmillan Ltd that explores the intersection of biological sciences, health policy, and the social sciences. Launched in 2006, this journal aims to foster a deeper understanding of how biological concepts are framed within societal contexts, addressing critical issues that resonate across disciplines. With an impact factor indicative of its influence in the field—ranking in the Q3 quartile for Health Policy and the Q2 quartile for Health (Social Science) as of 2023—BioSocieties stands as a significant resource for researchers, professionals, and students alike. The journal's rigorous editorial standards and commitment to interdisciplinary dialogue ensure that it remains at the forefront of contemporary health debates. The publication is based in the United Kingdom and continues to expand its reach, inviting contributions that engage with pressing health issues from a sociocultural perspective. While currently not open access, BioSocieties provides valuable insights and fosters scholarly engagement that is vital for policy-makers, healthcare professionals, and academics driving change in the health landscape.

Historia y Sociedad is a prominent open-access journal dedicated to the interdisciplinary study of history and society, published by the National University of Colombia's Faculty of Human Sciences. Launched in 2011, it aims to promote scholarly dialogue and research dissemination within the fields of historical analysis, social theory, and cultural studies. With its inclusive approach, the journal invites contributions that engage with both contemporary and historical issues, encouraging submissions from researchers, professionals, and students alike. Addressed to an international audience, Historia y Sociedad operates from its headquarters in Bogotá, Colombia, and enjoys a growing reputation for its relevant scholarship. The journal's commitment to open access reflects its dedication to making research widely available, fostering a more comprehensive understanding of societal dynamics across various contexts. Explore the rich tapestry of history and its impact on today's world through the lens of Historia y Sociedad.

CONTEMPORARY DRUG PROBLEMS is a distinguished academic journal published by SAGE PUBLICATIONS INC, focusing on critical issues within the realms of drug policy, health advocacy, and law. With a legacy dating back to its inception in 1973 and a noticeable convergence in subsequent years, the journal serves as a vital forum for researchers, practitioners, and policymakers engaged in understanding the multifaceted challenges related to drug use and its societal impacts. Holding an impressive Q2 ranking in both Health Policy and Health (social science), and a Q1 distinction in Law, the journal positions itself as an essential resource for advancing knowledge and fostering dialogue in these essential fields. Although it operates under traditional access models, its wide-ranging insights make it indispensable for those who aim to contribute meaningfully to the discourse surrounding contemporary drug issues. With its robust Scopus rankings, including a significant 89th percentile in Social Sciences Law, CONTEMPORARY DRUG PROBLEMS remains a pivotal source for scholars and professionals alike, striving to address and mitigate the complexities of drug-related problems on both a legal and social front.

Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.